Supplementary physicians' fees: a sustainable system?

Health Econ Policy Law

Department of Health Policy and Management, Erasmus University Rotterdam,The Netherlands.

Published: January 2019

In Belgium and France, physicians can charge a supplementary fee on top of the tariff set by the mandatory basic health insurance scheme. In both countries, the supplementary fee system is under pressure because of financial sustainability concerns and a lack of added value for the patient. Expenditure on supplementary fees is increasing much faster than total health expenditure. So far, measures taken to curb this trend have not been successful. For certain categories of physicians, supplementary fees represent one-third of total income. For patients, however, the added value of supplementary fees is not that clear. Supplementary fees can buy comfort and access to physicians who refuse to treat patients who are not willing to pay supplementary fees. Perceived quality of care plays an important role in patients' willingness to pay supplementary fees. Today, there is no evidence that physicians who charge supplementary fees provide better quality of care than physicians who do not. However, linking supplementary fees to objectively proven quality of care and limiting access to top quality care to patients able and willing to pay supplementary fees might not be socially acceptable in many countries. Our conclusion is that supplementary physicians' fees are not sustainable.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1744133117000548DOI Listing

Publication Analysis

Top Keywords

supplementary fees
36
quality care
16
supplementary
13
pay supplementary
12
fees
11
supplementary physicians'
8
physicians' fees
8
fees sustainable
8
physicians charge
8
charge supplementary
8

Similar Publications

This dataset originates from TeensLab, a consortium of Spanish Universities dedicated to behavioral research involving Spanish teenagers. The dataset contains data from 33 distinct educational institutions across Spain, accounting for a total of 5,890 students aged 10 to 23 (M = 14.10, SD = 1.

View Article and Find Full Text PDF

Evaluating the ability of large language models to emulate personality.

Sci Rep

January 2025

Shanghai Institute of AI for Education, East China Normal University, 3663 North Zhongshan Road, Shanghai, 200062, China.

For social sciences, recent advancements in Large Language Models (LLMs) have the potential to revolutionize the study of human behaviors by facilitating the creation of realistic agents characterized by a diverse range of individual differences. This research presents novel simulation studies assessing GPT-4's ability to role-play real-world individuals with diverse big five personality profiles. In simulation 1, emulated personality responses exhibited superior internal consistency, but also a more distinct and structured factor organization compared to the human counterparts they were based on.

View Article and Find Full Text PDF

Association between genetically predicted leisure and social activities and cardiovascular disease and other health outcomes.

Nat Cardiovasc Res

January 2025

Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, South Korea.

Participation in leisure and social activities (LSA) is associated with better health outcomes and lower mortality. Previous observational studies demonstrated a relationship between engagement in LSA and both mental and physical health. Although several studies examined the association between LSA and health outcomes, including cardiovascular disease, their possible causal relationship has not been studied.

View Article and Find Full Text PDF

Objectives: For US Medicare and Medicaid, single drug prices do not reflect the value of supplemental indications. Value-based indication-specific and weighted-average pricing has been suggested for drugs with multiple indications. Under indication-specific pricing, a distinct price is assigned to the differential value a drug offers in each indication.

View Article and Find Full Text PDF

Introduction: Programmed death-ligand 1 (PD-L1) is the main predictive biomarker used to identify patients with NSCLC who are eligible for treatment with immune checkpoint inhibitors. Despite its utility, the predictive capacity of PD-L1 is limited, necessitating the exploration of supplementary predictive biomarkers. In this report, we describe the prognostic value of / mutation status for overall survival (OS) in patients with NSCLC treated with first-line immunotherapy or combined chemoimmunotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!